Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8

André N. Vis; Liselotte M. S. Boevé

doi:https://doi.org/10.1016/j.eururo.2018.12.024

Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e131-e132
Journal	European Urology
Volume	75
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2018.12.024
Publication status	Published - May 2019

Access to Document

https://doi.org/10.1016/j.eururo.2018.12.024

Cite this

Vis, A. N., & Boevé, L. M. S. (2019). Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8. European Urology, 75(5), e131-e132. https://doi.org/10.1016/j.eururo.2018.12.024

Vis, André N. ; Boevé, Liselotte M. S. / Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8. In: European Urology. 2019 ; Vol. 75, No. 5. pp. e131-e132.

@article{0f545a49a20f4b9d9c16d326bd3c8751,

title = "Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boev{\'e}, Maarten C.C.M. Hulshof, Andr{\'e} N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8",

author = "Vis, {Andr{\'e} N.} and Boev{\'e}, {Liselotte M. S.}",

year = "2019",

month = may,

doi = "https://doi.org/10.1016/j.eururo.2018.12.024",

language = "English",

volume = "75",

pages = "e131--e132",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

Vis, AN & Boevé, LMS 2019, 'Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8', European Urology, vol. 75, no. 5, pp. e131-e132. https://doi.org/10.1016/j.eururo.2018.12.024

Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8. / Vis, André N.; Boevé, Liselotte M. S.
In: European Urology, Vol. 75, No. 5, 05.2019, p. e131-e132.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8

AU - Vis, André N.

AU - Boevé, Liselotte M. S.

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85063640707&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.eururo.2018.12.024

DO - https://doi.org/10.1016/j.eururo.2018.12.024

M3 - Letter

C2 - 30616950

SN - 0302-2838

VL - 75

SP - e131-e132

JO - European Urology

JF - European Urology

IS - 5

ER -

Vis AN , Boevé LMS. Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8. European Urology. 2019 May;75(5):e131-e132. doi: https://doi.org/10.1016/j.eururo.2018.12.024

Access to Document

Other files and links

Cite this